BLMIF (Bank Leumi Le-Israel BM) Research & Development: $0 Mil (TTM As of Mar. 2026)


BLMIF Bank Leumi Le-Israel BM BLMIF
72 GF Score
Price $21.50
GF Value $13.52
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Bank Leumi Le-Israel BM Research & Development?

Bank Leumi Le-Israel BM BLMIF 72 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates BLMIF with a GF Score™ of 72/100 and a GF Value™ of $13.52 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Bank Leumi Le-Israel BM's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Bank Leumi Le-Israel BM  (OTCPK:BLMIF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bank Leumi Le-Israel BM Research & Development Related Terms

Bank Leumi Le-Israel BM Research & Development Historical Data

* Premium members only.

The historical data trend for Bank Leumi Le-Israel BM's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bank Leumi Le-Israel BM Research & Development Chart

Bank Leumi Le-Israel BM Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bank Leumi Le-Israel BM Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BLMIF
72GF Score
Bank Leumi Le-Israel BM BLMIF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bank Leumi Le-Israel BM Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Bank Leumi Le-Israel BM (BLMIF) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Bank Leumi Le-Israel BM and its competitors.
Is Bank Leumi Le-Israel BM's Research & Development too high?
Bank Leumi Le-Israel BM's current Research & Development is $0 Mil. Overall, Bank Leumi Le-Israel BM has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bank Leumi Le-Israel BM's Research & Development compare to PNC and USB?
Bank Leumi Le-Israel BM's Research & Development of $0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Bank Leumi Le-Israel BM and its competitors. Bank Leumi Le-Israel BM's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bank Leumi Le-Israel BM stock overvalued right now?
Based on GuruFocus' analysis, Bank Leumi Le-Israel BM (BLMIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $13.52, compared to a current price of $21.50 — trading 59% above its estimated fair value. The current Research & Development is $0 Mil. Bank Leumi Le-Israel BM's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Bank Leumi Le-Israel BM (BLMIF), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bank Leumi Le-Israel BM (BLMIF) Overvalued in 2026?

Based on GuruFocus' analysis, Bank Leumi Le-Israel BM stock appears to be overvalued. The current stock price of $21.50 is trading 59% above its estimated GF Value™ of $13.52. GuruFocus considers Bank Leumi Le-Israel BM to be Significantly Overvalued.

Key valuation signals for BLMIF:

  • Research & Development: $0 Mil
  • GF Value™: $13.52 vs. price of $21.50 (59% above fair value)
  • GF Score™: 72/100 with 1 warning sign

No single metric tells the full story. See the BLMIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bank Leumi Le-Israel BM Business Description

Other Exchanges LUMI:Israel
Address 34 Yehuda Halevi Street, Tel Aviv, ISR, 651316
Bank Leumi Le-Israel BM is an Israeli banking and financial services company. The products and services offered by the company include consumer loans, mortgages, commercial banking services, and capital market services, among others. The company organizes itself into the following operating segments: Banking, Mortgages, Commercial, Corporate banking, Real estate, Capital markets, and Others. The company generates the majority of its revenue through the provision of banking and services to private customers and small businesses, and a vast majority of its revenue is earned in Israel.
72GF Score

Get the complete analysis for BLMIF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.50
Price
$13.52
GF Value